On February 14, 2024, Phoenix Biotech Acquisition Corp., pursuant to the business combination agreement and plan of reorganization, dated as of June 4, 2023, as amended by Amendment No. 1, dated as of February 5, 2024 and Amendment No. 2, dated as of February 13, 2024, by and between PBCE Merger Sub, Inc., a Delaware corporation, PBAX and CERo.

Brian Atwood was appointed as the Company?s Chief Executive Officer.